Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
TEVA
TEVA
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
Latest TEVA ETF News Today | Earnings, Events & Price Alerts
TEVA News
Teva Pharmaceutical Stock Doubles, Strong Outlook Ahead
1d ago
Fool
Teva Pharmaceutical's Investment Opportunities and Risks
3d ago
Fool
Teva Pharmaceuticals Faces Competition and Risks in Drug Development
3d ago
NASDAQ.COM
Bridger Management Sells Entire Stake in Bath & Body Works Amid Struggles
6d ago
Fool
Bridger Management Exits BBWI Stake Amid Market Challenges
6d ago
NASDAQ.COM
Teva's New Drug Application Accepted by FDA for Schizophrenia Treatment
Feb 23 2026
Benzinga
Teva and Medincell's NDA for Long-Acting Olanzapine Accepted by FDA
Feb 21 2026
seekingalpha
Teva and Medincell's NDA for Olanzapine Accepted by FDA
Feb 21 2026
NASDAQ.COM
TEVA's New Drug Application Accepted by FDA for Schizophrenia Treatment
Feb 20 2026
stocktwits
Teva's Long-Acting Injectable for Schizophrenia Receives FDA Acceptance
Feb 20 2026
Newsfilter
Corcept Loses Patent Appeal for Korlym, Shares Plunge
Feb 19 2026
stocktwits
Corcept Therapeutics Faces Significant Pressure as Shares Approach Lows
Feb 19 2026
Benzinga
Corcept Therapeutics Shares Plunge Over 20% After Patent Ruling
Feb 19 2026
seekingalpha
David Einhorn's Concerns on AI Overvaluation Impacting Stock Picks
Feb 18 2026
CNBC
Teva Pharmaceutical Stock Shows Strong Performance
Feb 17 2026
Yahoo Finance
Positive Data from Teva and Sanofi's IBD Study
Feb 17 2026
Benzinga
Show More News
